A new look at osteoporosis outcomes: The influence of treatment, compliance, persistence, and adherence

被引：20
|
作者：
Badamgarav, Enkhe [1 ]
Fitzpatrick, Lorraine A. [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
MAYO CLINIC PROCEEDINGS | 2006年 / 81卷 / 08期
关键词：
D O I：
10.4065/81.8.1009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1009 / 1012
页数：4
相关论文
共 50 条
  • [1] Factors that influence treatment outcomes, adherence and persistence with rivastigmine patch
    Blesa, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 853 - 853
  • [2] PERSISTENCE AND ADHERENCE TO DENOSUMAB FOR THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Parrotta, A.
    Muccari, G.
    De Luca, E.
    Gallo, G.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S287 - S288
  • [3] The potential impact of new effervescent alendronate formulation on compliance and persistence in osteoporosis treatment
    Marco Invernizzi
    C. Cisari
    S. Carda
    Aging Clinical and Experimental Research, 2015, 27 : 107 - 113
  • [4] The potential impact of new effervescent alendronate formulation on compliance and persistence in osteoporosis treatment
    Invernizzi, Marco
    Cisari, C.
    Carda, S.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2015, 27 (02) : 107 - 113
  • [5] Improving persistence and adherence to osteoporosis treatment: a challenge to solve
    Alarcon, T.
    Gonzalez-Montalvo, J. I.
    Martin-Vega, A.
    Gotor, P.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (03) : 1275 - 1276
  • [6] Improving persistence and adherence to osteoporosis treatment: a challenge to solve
    T. Alarcón
    J. I. González-Montalvo
    A. Martín-Vega
    P. Gotor
    Osteoporosis International, 2016, 27 : 1275 - 1276
  • [7] ARE PATIENT-REPORTED PERSISTENCE AND ADHERENCE TO TREATMENT FOR A CHRONIC DISEASE VALID OUTCOMES? AN EXAMPLE WITH OSTEOPOROSIS
    Senay, A.
    Perreault, S.
    Delisle, J.
    Morin, S. N.
    Banica, A.
    Laflamme, Y.
    Leduc, S.
    Mac-Thiong, J.
    Ranger, P.
    Rouleau, D.
    Fernandes, J. C.
    VALUE IN HEALTH, 2018, 21 : S2 - S2
  • [8] Compliance and persistence with osteoporosis therapies
    Silverman S.L.
    Gold D.T.
    Current Rheumatology Reports, 2008, 10 (2) : 118 - 122
  • [9] Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
    Hoeer, Ariane
    Seidlitz, Cornelia
    Gothe, Holger
    Schiffhorst, Guido
    Olson, Melvin
    Hadji, Peyman
    Haeussler, Bertram
    PATIENT PREFERENCE AND ADHERENCE, 2009, 3 : 25 - 30
  • [10] The impact of suboptimal adherence on osteoporosis treatment outcomes
    Adachi, R.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S110 - S110
12345